CME Accreditation Statement - Academy of Regenerative Practices

advertisement
14 AMA PRA Category 1 Credits™
Accreditation This activity has been planned and implemented in accordance with the Essential Areas
and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint
providership of the Foundation for Care Management (FCM) and The Academy of Regenerative
Practices.
The Foundation for Care Management (FCM) is accredited by the Accreditation Council for Continuing
Medical Education (ACCME) to provide continuing medical education for physicians.
FCM designates this educational activity for a maximum of 14 AMA PRA Category 1 Credits™.
Physicians should only claim credit commensurate with the extent of their participation in this activity.


Purpose of the course/mission statement/target audience
The ARP is dedicated to the education of medical practitioners in the latest cellular medicine
techniques and therapies. The ARP provides a forum for multiple disciplines to integrate and
learn the most advanced regenerative clinical applications. The goal of this conference is to give
you the tools necessary to implement regenerative medicine into your practice. Attending will be
MDs, DOs, NDs, PAs.
Disclosure Statements:
Dr. Harry Adelson has no financial interest in any of the products or manufacturers mentioned.
Dr. Mark Berman, MD, is a Co-Founder of Cell Surgical Network. He is Co-Medical Director of CA
Stem Cell Treatment Center and a Co-Founder of Cells on Ice.
Kristin Comella is a Speaker and Course Planner for Bioheart Inc.
Dr. Fabio Castro, MD has no financial interest in any of the products or manufacturers mentioned.
Dr. Ted Harrison has no financial interest in any of the products or manufacturers mentioned.
Dr. Jerry Leon has no financial interest in any of the products or manufacturers mentioned.
Dr. Robert Silbert has no financial interest in any of the products or manufacturers mentioned.
Dr. Allen Wu has no financial interest in any of the products or manufacturers mentioned.
Dr. Beatriz Zevallos has no financial interest in any of the products or manufacturers mentioned.
Planning Committee:
Beatriz Zevallos, MD, Lead Planner, Quality Control Officer, Harry Adelson, MD, Content Expert,
have no financial interest in any of the products or manufacturers mentioned. Mark Berman, MD,
is a Co-Founder of Cell Surgical Network. He is Co-Medical Director of CA Stem Cell Treatment
Center and a Co-Founder of Cells on Ice.
The ACCME defines a “Commercial Interest” as any entity producing, marketing, re-selling, or
distributing health care goods or services consumed by, or used on, patients.
Outcome objectives
Upon completion of this activity the healthcare provider will be able to:
1. Identify the basic technical aspects of BMAC harvest/concentration and SVF harvest/isolation
2. Recognize the practical aspects of patient selection, side effects, risks, and post-procedure
care between BMAC and SVF.
3. Compare the outcomes of patients treated with BMAC vs. SVF for osteoarthritis of the knee
and spine pain.
4. Discuss the incidence of low back pain and identify why use ADSC for the treatment of low
back pain.
5. Discuss why ADSC is different from BMAC treatment and which one is superior.
6. Recognize how intra-discal stem cell treatment compares to surgical fusion.
7. Identify the physiologic basis of prolotherapy.
8. Recognize the differences in PRP preparations.
9. Define the clinical evidence for the efficacy of PRP-prolotherapy treatment.
10. Discuss the available research on regenerative treatments.
11. Identify the biology of proper healing and the disease processes that impede healing.
12. Compare different cell types and explain the differences.
13. Determine appropriate patient candidacy for various stem cell treatments.
14. Perform and evaluate platelet rich plasma for use in musculoskeletal tissues
15. Discuss how stem cell injection therapies can be integrated into treatment protocols to
enhance proper healing and affect chronic pain conditions.
16. Assess several regenerative medicine techniques and solutions for treating chronic pain.
17. Describe regulatory environment of platelet rich plasma and autologous stem cell therapies.
Instructions for claiming credit
Please visit FCMcme.org to register or create an account.
You will then have a username and password.
To receive your online statement of credit, go to fcmcme.org/ARP
Enter the program Course Code ARP6615b1
Complete the pre-test exam.
Complete the post-test course evaluation.
You will then be able to print out your statement of credit.
Download